Toward improved understanding of the ethical and clinical issues surrounding mandatory research biopsies.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Clinical Oncology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2012.44.8589PMID 23129739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of research biopsies in clinical trials: are risks and benefits adequately discussed?

  2013cited by this paper
• Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety.

  2012cited by this paper
• The ethical use of mandatory research biopsies

  2011cited by this paper
• Ethics of mandatory research biopsy for correlative end points within clinical trials in oncology.

  2010cited by this paper
• Clinical Trials and Medical Care: Defining the Therapeutic Misconception

  2007cited by this paper
• Access before approval--a right to take experimental drugs?

  2006cited by this paper
• Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents.

  2006cited by this paper
• Sequential tumor biopsies in early phase clinical trials of anticancer agents for pharmacodynamic evaluation.

  2001cited by this paper
• Quality of informed consent in cancer clinical trials: a cross-sectional survey.

  2001cited by this paper
• Phase I cancer trials. A collusion of misunderstanding.

  2000cited by this paper
• Informed consent for phase I studies: evaluation of quantity and quality of information provided to patients.

  1995cited by this paper
• Can a clinical trial be the treatment of choice for patients with cancer?

  1988cited by this paper

• Data Sharing, Biopsies and Patient Confidentiality in a Precision Medicine Trial for Childhood Cancer: A Mixed Method Study of Parents, Oncologists, and Scientists’ Perspectives

  2025cites this paper
• An Expanded Role for IRBs in the Oversight of Research Biopsies.

  2022cites this paper
• Liquid biopsy in bone sarcomas and identification of new biomarkers

  2022cites this paper
• Analyses of the rationale and implementation of research biopsies in oncology clinical trials at a tertiary cancer center.

  2021cites this paper
• Tumour heterogeneity: Does it matter?

  2020cites this paper
• Secondary Use of Patient Tissue in Cancer Biobanks.

  2019cites this paper
• Aurora A–Selective Inhibitor LY3295668 Leads to Dominant Mitotic Arrest, Apoptosis in Cancer Cells, and Shows Potent Preclinical Antitumor Efficacy

  2019cites this paper
• Tumor heterogeneity: does it matter?

  2019cites this paper
• Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center

  2019cites this paper
• Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research Statement.

  2019cites this paper
• The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars

  2019cites this paper
• Optimization of a Novel In Situ Hybridization Technology on 3D Organotypic Cell Cultures

  2019cites this paper
• Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non–Small‐cell Lung Cancer: SWOG S0635 and S0636 Trials

  2018cites this paper
• Attitudes of patients with metastatic cancer towards research biopsies

  2018influential citation
• Application of liquid biopsy in bone and soft tissue sarcomas: Present and future.

  2018cites this paper
• State of Panax ginseng Research: A Global Analysis

  2017cites this paper
• Attitudes of patients and physicians on repeat biopsies for lung cancer

  2017cites this paper
• Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer

  2017cites this paper
• NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2

  2017cites this paper
• Masticadienonic and 3α-OH Masticadienoic Acids Induce Apoptosis and Inhibit Cell Proliferation and Tumor Growth in Prostate Cancer Xenografts In Vivo

  2017cites this paper
• Liquid Biopsies for Cancer: Coming to a Patient near You

  2017cites this paper
• Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors.

  2017cites this paper
• Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations

  2017cites this paper
• Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling

  2016cites this paper
• Resistance to Tyrosine Kinase Inhibitors in Different Types of Solid Cancer

  2016cites this paper
• Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With nab-Paclitaxel and Gemcitabine

  2016cites this paper
• Patients with Advanced Non–Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials?

  2016cites this paper
• The effects of the Bali Yoga Program (BYP-BC) on reducing psychological symptoms in breast cancer patients receiving chemotherapy: results of a randomized, partially blinded, controlled trial

  2016cites this paper
• Clinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach

  2016cites this paper
• 3-D nasal cultures: Systems toxicological assessment of a candidate modified-risk tobacco product.

  2016cites this paper
• Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple-Negative Breast Cancer

  2016cites this paper
• Frontiers in Cancer Research

  2016cites this paper
• Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.

  2016cites this paper
• Neurocognitive Late Effects in Children with Cancer

  2016cites this paper
• The Darwinian Dynamics of Motility and Metastasis

  2016cites this paper
• ALK e Cancro do Pulmão: o futuro é hoje?

  2016cites this paper
• Grundlagen für eine erfolgreiche Portimplantation

  2016cites this paper
• Discussion: Breast implant-associated anaplastic large cell lymphoma: a systematic review.

  2015cites this paper
• Participation in Cancer Pharmacogenomic Studies: A Study of 8456 Patients Registered to Clinical Trials in the Cancer and Leukemia Group B (Alliance).

  2015cites this paper
• TNFα sensitizes neuroblastoma cells to FasL-, cisplatin- and etoposide-induced cell death by NF-κB-mediated expression of Fas

  2015cites this paper
• Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

  2015cites this paper
• Ethical Issues in the Management of Renal Cell Carcinoma.

  2015cites this paper
• Gestational trophoblastic neoplasm and women living with HIV and/or AIDS

  2015cites this paper
• Metastasiertes Prostatakarzinom

  2015cites this paper
• Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC

  2015cites this paper
• What are the indications for postchemotherapy retroperitoneal lymph node dissection?

  2014cites this paper
• Novel treatment strategies for brain tumors and metastases.

  2014cites this paper
• Antiangiogenic therapy of brain tumors: the role of bevacizumab

  2014cites this paper
• A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer

  2014cites this paper
• A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up

  2014cites this paper
• Comparison of volumetric breast density estimations from mammography and thorax CT

  2014cites this paper
• Antiangiogenic therapies for glioblastoma.

  2014cites this paper
• Patients' Perceptions of Research Biopsies in Phase I Oncology Trials

  2014cites this paper
• Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations

  2013cites this paper
• Emerging paradigms in the development of resistance to tyrosine kinase inhibitors in lung cancer.

  2013cites this paper
• Prospective clinical experience with research biopsies in breast cancer patients

  2013cites this paper
• Prevalence and impact of correlative science in breast cancer phase II trials

  2013cites this paper
• Prospective clinical experience with research biopsies in breast cancer patients.

  2013cites this paper